Genovate Biotechnology Market Cap

Genovate Biotechnology has a market cap or net worth of 3.09 billion as of May 8, 2026. Its market cap has increased by 34.35% in one year.

Market Cap

3.09B

Enterprise Value

2.61B

Revenue

492.41M

Ranking

n/a

PE Ratio

272.00

Stock Price

27.20

Market Cap Chart

Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.09B, an increase of 365.40%. That is a compound annual growth rate of 9.17%.

Market Cap History

Date	Market Cap	% Change
May 8, 2026	3.09B	-1.81%
Dec 31, 2025	3.15B	35.56%
Dec 31, 2024	2.32B	-20.11%
Dec 29, 2023	2.91B	-17.02%
Dec 30, 2022	3.51B	31.05%
Dec 30, 2021	2.68B	-15.11%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Energenesis Biomedical CO.,LTD.	3.61B
BioGend Therapeutics	3.52B
Shine-On BioMedical	3.21B
SYN-TECH Chem. & Pharm.	3.21B
TWi Biotechnology	3.03B
Intech Biopharm	3.02B
BRIM Biotechnology	2.98B
Chunghwa Chemical Synthesis & Biotech	2.98B

Market Cap Rankings